---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-021210"
form_type: "8-K"
ticker: "BCDA"
cik: "0000925741"
company_name: "BioCardia, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T21:48:50.843750+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# BioCardia granted US Patent No. 12,311,127 for Helix catheter delivery system

## Summary
- Patent covers radial and trans-endocardial delivery catheter for biologic therapies.
- Protects helical needle-tipped catheter platform; cited as safest and most efficient approach.
- Helix system underlies CardiAMP Cell Therapy program for ischemic cardiomyopathies and refractory angina.
- CEO notes work toward separate approvals of the therapy and the delivery system.

## SEC filing metadata
- accession: 0001437749-25-021210
- form_type: 8-K
- ticker: BCDA
- cik: 0000925741
- company_name: BioCardia, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/0001437749-25-021210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/925741/000143774925021210/bcda20250625_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-021210
- JSON: https://secwatch.observer/filing/0001437749-25-021210.json
- Plain text: https://secwatch.observer/filing/0001437749-25-021210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.